AZ's Truqap and Roche assay cleared for PTEN prostate cancer
AstraZeneca has claimed a second approval for AKT inhibitor Truqap, in prostate cancer, that should help achieve its blockbuster hopes for the drug.
Newsletters and Deep Dive digital magazine
AstraZeneca has claimed a second approval for AKT inhibitor Truqap, in prostate cancer, that should help achieve its blockbuster hopes for the drug.
Less than 30% of digital transformations succeed across industries, while biopharma remains significantly behind (~20% succeed), with only a small minority of companies achieving scaled, en
Novo Nordisk's fast-growing Wegovy pill has been approved in the UK for weight loss, its first European market.
Eli Lilly has recruited basketball legend Shaquille O'Neal to promote a sleep apnoea awareness campaign and make the case for treatment with Zepbound.
Lilly's Ebglyss has claimed an FDA approval for less-frequent maintenance dosing that could give it an edge over market leader Dupixent.
Editor's Picks
Newsletters and Deep Dive
digital magazine